Re: Short interest climbs to 185,900
|
2
|
Resverlogix Corp.
|
Sep 21, 2017 01:48PM
|
Re: Still waiting for a sufficient answer
|
2
|
Resverlogix Corp.
|
May 19, 2018 10:41AM
|
Re: Globe n Mail this am.
|
2
|
Zenith Epigenetics
|
Feb 03, 2018 11:49AM
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
2
|
Resverlogix Corp.
|
Jun 11, 2021 11:32AM
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
2
|
Resverlogix Corp.
|
Dec 18, 2017 01:11PM
|
Re: nice drop!
|
2
|
Resverlogix Corp.
|
Feb 24, 2020 06:41PM
|
Re: Pointing in the right direction & bogus Lilly
|
2
|
Resverlogix Corp.
|
Jun 21, 2018 09:22PM
|
Re: The Top 5 TSX Biotechs for 2018 so far - Guess which one they missed.....
|
2
|
Resverlogix Corp.
|
Dec 26, 2018 11:11AM
|
Re: Hepalink IPO Document and what it says about RVX
|
2
|
Resverlogix Corp.
|
Jan 29, 2020 03:20AM
|
Re: Gonna check back for the last 15 mintues....
|
2
|
Resverlogix Corp.
|
Apr 08, 2019 10:44PM
|
Re: Fun and games?
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 02:19PM
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 19, 2020 11:35PM
|
Re: My head is spinning.....
|
2
|
Resverlogix Corp.
|
Sep 29, 2019 01:03AM
|
Re: I believe the big/long wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2023 12:28PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
2
|
Zenith Epigenetics
|
Feb 11, 2019 10:41PM
|
Re: Pan versus Selective Inhibitors....I need analogies
|
2
|
Resverlogix Corp.
|
Nov 22, 2017 06:20PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 05:09PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 24, 2019 01:45AM
|
Re: To Be or Not to Be?
|
2
|
Resverlogix Corp.
|
Aug 11, 2021 10:11PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 27, 2022 01:58AM
|